Human Immunoglobulin (Ph4) For Intravenous Injection Found To Be Effective In Treatment Of Covid-19

Indrayani_p31 May, 2021Health

Unlike subcutaneous immunoglobulin, which must be metabolized before entering the body, in vitro vaccines require that the substance is first introduced into the body. Once in the body, antibodies created in the laboratory are able to actively combat diseases and infections. In many cases, it has been observed that the plasma therapy or administration of human immunoglobulin (pH4) for intravenous injection (COVID-19) found to be effective in the treatment of COVID-19.